ConductScience.org, home

Paper39587352

The consequences of SARS-CoV-2 within-host persistence.

Sigal A and 2 others. Nat Rev Microbiol, 2025. Cited by 25 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The consequences of SARS-CoV-2 within-host persistence. Papers, record 39587352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39587352

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The consequences of SARS-CoV-2 within-host persistence.
PubMed
Journal
Nat Rev Microbiol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
6.21, provisional
iCite
Revised in PubMed
2026-11-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sigal AAlexhttps://orcid.org/0000-0001-8571-2004
2Neher RARichard Ahttps://orcid.org/0000-0003-2525-1407
3Lessells RJRichard Jhttps://orcid.org/0000-0003-0926-710X

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
COVID-19Major topic
Humans
Virus Replication
Mutation
Antibodies, Neutralizing

Source PubMed

References223

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135,597,249Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.Lancet Glob Health2022https://conductscience.org/library/papers/35597249PubMed
232,017,770Interference with HIV infection of the first cell is essential for viral clearance at sub-optimal levels of drug inhibition.PLoS Comput Biol2020https://conductscience.org/library/papers/32017770PubMed
337,539,764The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future.J Infect Dis2023https://conductscience.org/library/papers/37539764PubMed
434,942,634Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022https://conductscience.org/library/papers/34942634PubMed
538,663,423The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China.Lancet Infect Dis2024https://conductscience.org/library/papers/38663423PubMed
634,431,691Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.mSphere2021https://conductscience.org/library/papers/34431691PubMed
736,007,063SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.PLoS Pathog2022https://conductscience.org/library/papers/36007063PubMed
835,996,593Recurrent SARS-CoV-2 mutations in immunodeficient patients.Virus Evol2022https://conductscience.org/library/papers/35996593PubMed
931,676,304Persistent Dengue Infection in an Immunosuppressed Patient Reveals the Roles of Humoral and Cellular Immune Responses in Virus Clearance.Cell Host Microbe2019https://conductscience.org/library/papers/31676304PubMed
1034,796,242The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.Open Forum Infect Dis2021https://conductscience.org/library/papers/34796242PubMed
1137,270,625Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants.Nat Commun2023https://conductscience.org/library/papers/37270625PubMed
127,541,846Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.J Virol1995https://conductscience.org/library/papers/7541846PubMed
1333,431,879Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).Nat Commun2021https://conductscience.org/library/papers/33431879PubMed
1434,903,718Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load.Nat Commun2021https://conductscience.org/library/papers/34903718PubMed
1529,514,238Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort.Clin Infect Dis2018https://conductscience.org/library/papers/29514238PubMed
1638,487,021B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experience.Front Med (Lausanne)2024https://conductscience.org/library/papers/38487021PubMed
1736,717,718Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus.Nat Microbiol2023https://conductscience.org/library/papers/36717718PubMed
1838,720,002An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution.Nat Med2024https://conductscience.org/library/papers/38720002PubMed
1938,266,109SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency.Sci Transl Med2024https://conductscience.org/library/papers/38266109PubMed
2036,517,603SARS-CoV-2 infection and persistence in the human body and brain at autopsy.Nature2022https://conductscience.org/library/papers/36517603PubMed

See all 223 references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42,903,367Microbial PAMPs-PRR driven neuroimmune signaling in the development of post-infectious persistent pain.Anesthesiol Perioper Sci2026https://conductscience.org/library/papers/42903367PubMed
42,515,087NTD Remodeling in the SARS-CoV-2 BA.3.2 Variant May Influence Spike Stability and Immune Escape.Pathogens2026https://conductscience.org/library/papers/42515087PubMed
42,367,880SARS-CoV-2 saltational events are recurrent and trace to persistent human infections.bioRxiv2026https://conductscience.org/library/papers/42367880PubMed
42,145,722Intrahost viral evolution of SARS-CoV-2 infections in rheumatic versus hematological patients with severe iatrogenic immunosuppression.Front Med (Lausanne)2026https://conductscience.org/library/papers/42145722PubMed
42,037,411Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants.J Virol2026https://conductscience.org/library/papers/42037411PubMed
41,915,390Postacute Sequelae Following Omicron COVID-19 in Patients With Cancer.JAMA Netw Open2026https://conductscience.org/library/papers/41915390PubMed
41,884,606Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariant.Virus Evol2026https://conductscience.org/library/papers/41884606PubMed
41,880,345The impact of viral and host factors on the influenza A virus transmission bottleneck.PLoS Pathog2026https://conductscience.org/library/papers/41880345PubMed
41,739,834Viral evolution during primary infection in immunocompromised hosts.PLoS Comput Biol2026https://conductscience.org/library/papers/41739834PubMed
41,688,712Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort.Commun Med (Lond)2026https://conductscience.org/library/papers/41688712PubMed
41,633,357Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infections.Cell Rep Med2026https://conductscience.org/library/papers/41633357PubMed
41,629,286Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2.Signal Transduct Target Ther2026https://conductscience.org/library/papers/41629286PubMed
41,384,162Expanding the causes of Fever of Unknown Origin in immunocompromised patients: report of two cases highlighting the role of SARS-CoV-2.Infez Med2025https://conductscience.org/library/papers/41384162PubMed
41,157,582Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID.Viruses2025https://conductscience.org/library/papers/41157582PubMed
41,090,722The Effect of Long-Term Betacoronavirus Infection on the Permeability of the Blood-Brain Barrier-In Vitro Model Studies.Cells2025https://conductscience.org/library/papers/41090722PubMed
41,031,289Phylogenetic meta-analysis of persistent SARS-CoV-2 infections in immunocompromised individuals highlights the challenges of robust evolutionary rate estimation caused by low genetic diversity.Virus Evol2025https://conductscience.org/library/papers/41031289PubMed
40,933,128Isolation of a SARS-CoV-2 strain from pediatric patients in South Korea: biologic and genetic characterization.Front Microbiol2025https://conductscience.org/library/papers/40933128PubMed
40,872,325Relationship Between Cell Surface Viral Glycoprotein Expression and Resistance of Parainfluenza Virus Persistently Infected Cells to Complement-Mediated Lysis.Pathogens2025https://conductscience.org/library/papers/40872325PubMed
40,721,817Perioperative and anesthetic considerations for post-acute sequelae of COVID (PASC)/long COVID.Perioper Med (Lond)2025https://conductscience.org/library/papers/40721817PubMed
40,695,836Hamsters with long COVID present distinct transcriptomic profiles associated with neurodegenerative processes in brainstem.Nat Commun2025https://conductscience.org/library/papers/40695836PubMed

See all 23 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39587352

GET https://conductscience.org/api/papers/v1/39587352/references?page=2